BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17484931)

  • 21. Vox populi: Using community-based studies to determine best management of early-stage nonseminoma.
    Nichols CR; Kollmannsberger C
    J Clin Oncol; 2009 May; 27(13):2114-6. PubMed ID: 19307494
    [No Abstract]   [Full Text] [Related]  

  • 22. Modern trends in the management of non-seminomas.
    Base J; Navrátil P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(1):77-86. PubMed ID: 6085881
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
    Albers P; Algaba F; Cohn-Cedermark G; DeSantis M; Kliesch S; Moul JW
    Urology; 2011 Oct; 78(4 Suppl):S427-34. PubMed ID: 21986222
    [No Abstract]   [Full Text] [Related]  

  • 24. [Testicular tumors--a curable disease?].
    Brunner KW; Sonntag RW; Joss R
    Schweiz Rundsch Med Prax; 1988 May; 77(20):560-4. PubMed ID: 2838878
    [No Abstract]   [Full Text] [Related]  

  • 25. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis, diagnosis and therapy of testicular tumors].
    Weissbach I; Bussar-Maatz R
    Urologe A; 1996 Mar; 35(2):163-72. PubMed ID: 8650851
    [No Abstract]   [Full Text] [Related]  

  • 27. The medical-surgical nurse's guide to testicular cancer.
    Bohnenkamp S; Yoder LH
    Medsurg Nurs; 2009; 18(2):116-23; quiz 124. PubMed ID: 19489211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonseminomatous germ celL testicular tumors. Review of the UCL experience.
    Van Cangh PJ; Lefebvre YJ; Humblet YP; Hennebert PN; Wese FX; Opsomer RJ
    Acta Urol Belg; 1985; 53(2):394-410. PubMed ID: 2990184
    [No Abstract]   [Full Text] [Related]  

  • 29. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis].
    Bokemeyer C; Kuczyk MA; Köhne CH; Haupt A; Schmoll HJ
    Med Klin (Munich); 1996 Nov; 91(11):703-10. PubMed ID: 9036294
    [No Abstract]   [Full Text] [Related]  

  • 31. Improvement in the outcome of children with germ cell tumors.
    Lopes LF; Sonaglio V; Ribeiro KC; Schneider DT; de Camargo B
    Pediatr Blood Cancer; 2008 Feb; 50(2):250-3. PubMed ID: 17554793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The results of the treatment of stage I and II nonseminomatous germinal testicular tumors.
    Akdaş A; Ilker Y; Kirkali Z; Bakkaloğlu M
    Turk J Pediatr; 1984; 26(1-4):291-6. PubMed ID: 6100345
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bilateral testicular germ cell cancer].
    Lalowicz I
    Pol Merkur Lekarski; 1998 Sep; 5(27):155-6. PubMed ID: 10101485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors].
    May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B
    Urologiia; 2007; (2):58-63. PubMed ID: 17578200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ-cell tumors.
    Kondagunta V; Galsky MD; Sonpavde G
    N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969229
    [No Abstract]   [Full Text] [Related]  

  • 36. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL
    Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options].
    Ebbing J; Christoph F; Kempkensteffen C; Weikert S; Schostak M; Hinz S; Lein M; Miller K; Schrader M
    Aktuelle Urol; 2008 Nov; 39(6):429-35. PubMed ID: 18979397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage I testicular cancer management and necessity for surgical expertise.
    Sheinfeld J; Motzer RJ
    J Clin Oncol; 2008 Jun; 26(18):2934-6. PubMed ID: 18458042
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin.
    Kimura M; Onozawa M; Fujisaki A; Arakawa T; Takeda K; Dalmau J; Hattori K
    Int J Urol; 2008 Oct; 15(10):942-3. PubMed ID: 19138287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.